Jump to content

Category:Experimental anti-obesity drugs

From Wikipedia, the free encyclopedia

Subcategories

This category has the following 5 subcategories, out of 5 total.

A

Amylin receptor agonists (8 P)

C

Cannabinoid receptor antagonists (1 C, 1 P)

G

Glucagon receptor agonists (9 P)

M

METAP2 inhibitors (3 P)

N

Neuropeptide Y antagonists (5 P)

Pages in category "Experimental anti-obesity drugs"

The following 20 pages are in this category, out of 20 total. This list may not reflect recent changes.

0–9

5-HT2C receptor agonist

A

B

C

Cetilistat

D

E

Etiocholanedione

F

Fluasterone

G

GLY-200

H

HU6

M

Monlunabant

O

Orforglipron

P

Prohibitin-targeting peptide 1

S

T

Tesofensine

V

Vutiglabridin

Retrieved from "https://en.wikipedia.org/w/index.php?title=Category:Experimental_anti-obesity_drugs&oldid=1187871317"